Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
Tysabri (natalizumab)
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
Condition-specific preference-based measures: benefit or burden?
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS.
Analysis of CD4+CD8+ double positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
[Case report: a case of chronic inflammatory demyelinating polyneuropathy (CIDP) exacerbated by influenza vaccination].
Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.
Prognostic indicators for long-term disability in multiple sclerosis patients.
Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis.
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.
Endovascular correction of cerebrovenous anomalies in Multiple Sclerosis: A retrospective review of an uncontrolled case series.
Electromagnetic Field Stimulation Potentiates Endogenous Myelin Repair by Recruiting Subventricular Neural Stem Cells in an Experimental Model of White Matter Demyelination.
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Extreme Stability of Chitotriosidase in Cerebrospinal Flulid makes it a Suitable Marker for Microglial Activation in Clinical Trials.
Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs.
Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.
Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model.
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
Is the treatment of multiple sclerosis headed in the wrong direction?
Pages
« first
‹ previous
…
179
180
181
182
183
184
185
186
187
…
next ›
last »